Literature DB >> 29066591

The Role of Rescue Therapies in the Treatment of Severe ARDS.

Francesco Alessandri1, Francesco Pugliese2, V Marco Ranieri2.   

Abstract

ARDS is characterized by a non-cardiogenic pulmonary edema with bilateral chest radiograph opacities and hypoxemia refractory to oxygen therapy. It is a common cause of admission to the ICU due to hypoxemic respiratory failure requiring mechanical ventilation. Corticosteroids are not recommended in ARDS patients. Rescue therapies alleviate hypoxemia in patients unable to maintain reasonable oxygenation: recruitment maneuvers, prone positioning, inhaled nitric oxide, high-frequency oscillatory ventilation, and extracorporeal membrane oxygenation improve oxygenation, but their impact on mortality remains unproven. Restrictive fluid management seems to be a favorable strategy with no significant reduction in 60-d mortality. Future studies are needed to clarify the efficacy of these therapies on outcomes in patients with severe ARDS, and institution of these therapies may be considered on a case-by-case basis.
Copyright © 2018 by Daedalus Enterprises.

Entities:  

Keywords:  extracorporeal membrane oxygenation; prone position; refractory hypoxemia; rescue therapies; severe ARDS; ventilatory setting

Mesh:

Substances:

Year:  2017        PMID: 29066591     DOI: 10.4187/respcare.05752

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  14 in total

1.  Clinical Outcomes of Critically Ill Patients Using Inhaled Nitric Oxide (iNO) during Intrahospital Transport.

Authors:  Leonid Koyfman; Omri Simchon; Anna Koyfman; Shoshana Mushaev; Benjamin F Gruenbaum; Ron Gal; Michael Friger; Natan Arotsker; Alexander Zlotnik; Moti Klein; Evgeni Brotfain
Journal:  Crit Care Res Pract       Date:  2021-05-05

2.  Prone Positioning for ARDS: still misunderstood and misused.

Authors:  Francesco Pugliese; Cristina Babetto; Francesco Alessandri; Vito Marco Ranieri
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

Review 3.  Salvage therapies for refractory hypoxemia in ARDS.

Authors:  Sujith V Cherian; Anupam Kumar; Karunakar Akasapu; Rendell W Ashton; Malaygiri Aparnath; Atul Malhotra
Journal:  Respir Med       Date:  2018-07-03       Impact factor: 3.415

4.  Meta-Analysis of Preclinical Studies of Fibrinolytic Therapy for Acute Lung Injury.

Authors:  Cong Liu; Yana Ma; Zhenlei Su; Runzhen Zhao; Xiaoli Zhao; Hong-Guang Nie; Ping Xu; Lili Zhu; Mo Zhang; Xiumin Li; Xiaoju Zhang; Michael A Matthay; Hong-Long Ji
Journal:  Front Immunol       Date:  2018-08-20       Impact factor: 7.561

5.  Characteristics and Outcomes of Severe ARDS Patients Receiving ECMO in Southern Thailand.

Authors:  Nawaporn Assanangkornchai; Polathep Vichitkunakorn; Rungsun Bhurayanontachai
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2019-11-01

6.  Effect of early restrictive fluid resuscitation on inflammatory and immune factors in patients with severe pelvic fracture.

Authors:  La-Mei Jiang; Jun He; Xiao-Yan Xi; Chun-Mei Huang
Journal:  Chin J Traumatol       Date:  2019-09-20

7.  Neutrophil Extracellular Traps Augmented Alveolar Macrophage Pyroptosis via AIM2 Inflammasome Activation in LPS-Induced ALI/ARDS.

Authors:  Haitao Li; Yi Li; Chao Song; Yongbin Hu; Minhui Dai; Ben Liu; Pinhua Pan
Journal:  J Inflamm Res       Date:  2021-09-21

Review 8.  Critical role of nitric oxide in impeding COVID-19 transmission and prevention: a promising possibility.

Authors:  Rajalakshmi Rajendran; Anjana Chathambath; Abdullah G Al-Sehemi; Mehboobali Pannipara; Mazhuvancherry Kesavan Unnikrishnan; Lotfi Aleya; Roshni Pushpa Raghavan; Bijo Mathew
Journal:  Environ Sci Pollut Res Int       Date:  2022-03-08       Impact factor: 5.190

Review 9.  A comprehensive review on drug repositioning against coronavirus disease 2019 (COVID19).

Authors:  Maryam Rameshrad; Majid Ghafoori; Amir Hooshang Mohammadpour; Mohammad Javad Dehghan Nayeri; Hossein Hosseinzadeh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-05-19       Impact factor: 3.000

Review 10.  An Update on Current Therapeutic Drugs Treating COVID-19.

Authors:  Renyi Wu; Lujing Wang; Hsiao-Chen Dina Kuo; Ahmad Shannar; Rebecca Peter; Pochung Jordan Chou; Shanyi Li; Rasika Hudlikar; Xia Liu; Zhigang Liu; George J Poiani; Louis Amorosa; Luigi Brunetti; Ah-Ng Kong
Journal:  Curr Pharmacol Rep       Date:  2020-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.